Virios Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
2.830
-1.045 (-26.97%)
At close: Oct 9, 2024, 4:00 PM
2.570
-0.260 (-9.19%)
Pre-market: Oct 10, 2024, 5:10 AM EDT
Virios Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 3.02 | 3.32 | 7.03 | 14.01 | 29.8 | 0.31 | |
Cash & Short-Term Investments | 3.02 | 3.32 | 7.03 | 14.01 | 29.8 | 0.31 | |
Cash Growth | -34.20% | -52.82% | -49.81% | -52.99% | 9530.55% | 930.39% | |
Other Receivables | - | - | - | - | - | 0 | |
Receivables | - | - | - | - | - | 0 | |
Prepaid Expenses | 0.39 | 0.71 | 1.18 | 1.35 | 1.59 | 0.01 | |
Other Current Assets | 0.23 | 0.14 | 0.16 | 0.42 | 0.09 | - | |
Total Current Assets | 3.64 | 4.17 | 8.37 | 15.78 | 31.47 | 0.32 | |
Accounts Payable | 0.22 | 0.11 | 0.57 | 0.35 | 0.37 | 0.04 | |
Accrued Expenses | 0.28 | 0.25 | 0.47 | 0.92 | 1.16 | 1.59 | |
Total Current Liabilities | 0.5 | 0.36 | 1.04 | 1.28 | 1.53 | 1.62 | |
Long-Term Debt | - | - | - | - | - | 3.64 | |
Common Stock | 0 | 0 | 0 | 0 | 0 | 12.6 | |
Additional Paid-In Capital | 67.24 | 65.57 | 63.5 | 58.43 | 57.91 | - | |
Retained Earnings | -63.81 | -61.47 | -56.17 | -43.93 | -27.97 | -17.62 | |
Treasury Stock | -0.3 | -0.3 | - | - | - | - | |
Total Common Equity | 3.14 | 3.81 | 7.33 | 14.5 | 29.94 | -5.02 | |
Total Liabilities & Equity | 3.64 | 4.17 | 8.37 | 15.78 | 31.47 | 0.32 | |
Total Debt | - | - | - | - | - | 3.64 | |
Net Cash (Debt) | 3.02 | 3.32 | 7.03 | 14.01 | 29.8 | -3.33 | |
Net Cash Growth | -34.20% | -52.82% | -49.81% | -52.99% | - | - | |
Net Cash Per Share | 3.75 | 4.42 | 15.88 | 42.04 | 151.18 | -17.22 | |
Filing Date Shares Outstanding | 1.11 | 0.77 | 0.73 | 0.33 | 0.33 | 0.19 | |
Total Common Shares Outstanding | 1.11 | 0.77 | 0.73 | 0.33 | 0.33 | 0.19 | |
Working Capital | 3.14 | 3.81 | 7.33 | 14.5 | 29.94 | -1.3 | |
Book Value Per Share | 2.82 | 4.94 | 9.99 | 43.52 | 90.13 | -25.96 | |
Tangible Book Value | 3.14 | 3.81 | 7.33 | 14.5 | 29.94 | -5.02 | |
Tangible Book Value Per Share | 2.82 | 4.94 | 9.99 | 43.52 | 90.13 | -25.96 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.